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Background: Although Helicobacter Pylori (HP) was detected in some cases of chronic laryngitis, the results were
not confirmed by polymerase chain reaction (PCR). By this time, it has not been found in laryngeal lesions by in
house PCR, the most sensitive method for detecting the genome tracks. Regarding the previous results and also
few numbers of studies about the presence of HP in benign laryngeal lesions, specifically by PCR, we aimed to
investigate the presence of HP in benign laryngeal lesions by in-house PCR.
Methods: The samples were taken from 55 patients with benign laryngeal lesions and frozen in −20°C. One
milliliter (ml) of lysis buffer was added to 100 mg (mg) of each sample and the tube was placed in 56°C overnight.
Then DNA extraction was carried out.
Results: To find HP DNA, in-house PCR was performed that revealed 5 positive results among 55 patients with
benign laryngeal lesions. Of them, 3 were polyp, 1 was nodule and 1 was papilloma.
Conclusion: Although the number of positive results was not a lot in this study, it was in contrast with previous
studies which could not find any HP tracks in benign laryngeal lesions by other methods. More studies about the
prevalence of HP in benign laryngeal lesions improve judging about the effect of this infection on benign laryngeal
lesions.
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Helicobacter pylori (HP) is one of the risk factors of
adenocarcinoma. Thus, it was categorized as a carcino-
gen in 1994 by the World Health Organization (WHO)
[1,2]. Recent studies have revealed that HP can be re-
sponsible for the pathogenesis of upper gastro-esopha-
geal tract lesions such as oral cavity. It could be found in
dental plaques and secretions of the salivary glands, even
when gastric involvement was not detected [3-9].
HP was detected in some cases of chronic laryngitis
(6/35) by rapid urease test [10]. However, it has not
been confirmed by histology, tissue cultures, immuno-
histochemical methods or polymerase chain reaction* Correspondence: aslanahmadi8931@gmail.com
1Head and Neck Research Center, Hazrat Rasoul Akram Hospital, Tehran
University of Medical Sciences, Tehran, Iran
Full list of author information is available at the end of the article
© 2012 Izadi et al; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or(PCR) in benign laryngeal lesions [11,12]. Previous
tests showed false positive or false negative results, re-
gardless of the behavior of the lesion (malignant or
benign) [11,13].
PCR is one of the most progressive methods in mo-
lecular biology and recombinant DNA technology. The
technique is used to detect smallest particles in clinical
specimens with a high specificity and sensitivity [14].
The last study performed in Turkey to investigate HP
in laryngeal lesions by real-time PCR and in house PCR,
revealed that 58.6 % of benign laryngeal lesions were
infected with HP by real time PCR, but they didn’t detect
HP by in house PCR [15] (Figure 1). Following that art-
icle and also the absence of other previous studies about
the presence of HP in benign laryngeal lesions, specific-
ally by PCR, we aimed to investigate the presence of HP
in benign laryngeal lesions by in house PCR.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Different methods used to find helicobacter Pylori in laryngeal lesions, from past to now.
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Ethical approval
The protocol of this study was approved by the institu-
tional review board of the ENT research center of
Rasul-e-Akram Hospital, Tehran University of Medical
Sciences (TUMS). Before starting the investigation, ver-
bal consent was established and the aim of the study
was explained to all participants. Our patients did not
agree to undergo endoscopy for investigation of HP in
stomach.
To diagnose patients’ disorders, the specimens were
obtained from laryngeal masses. It was used for our
study, if the diagnosis was confirmed as a benign laryn-
geal lesion. The costs were supported by the institu-
tional board.
Study design and participants
This study was an observational cross-sectional study.
Fifty five specimens with confirmed benign laryngeal
lesion were evaluated for HP existence in the involved
tissue. The patients with the symptoms of gastro-esophageal reflux disease (GERD) or positive history
of using anti-HP drugs during the last month were
excluded from the study.
Patients with GERD symptoms usually use some
anti HP drugs even when the diagnosis is not con-
firmed with the gold standard. Regarding the ethical
aspects of the study, we could not use 24-h PH
monitoring (as the gold standard) or upper gastro-
intestinal tract endoscopy for the diagnosis. To make
sure that the entered patients did not use any anti
HP drugs, we examined the patients with GERD
symptoms.
Any kinds of manipulations of intact and healthy la-
ryngeal tissue can interfere with the vocal cords strength.
In the other hand, designing the control group in our
study should be based on the prevalence of the HP
among intact laryngeal tissues. Regarding the illegal
aspects of case–control study, we did not consider any
control groups for our study. To compare the results
with the frequency of HP in healthy tissues, we searched
for other investigations despite the illegal entity of the
Table 1 The prevalence of positive results among 55
patients with benign laryngeal lesions
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tact laryngeal tissue was found for comparison.
Preparation of tissue samples
The tissue samples (2 × 2.5 mm of the laryngeal lesion)
were extracted from 55 patients with benign laryngeal
lesions in Rasul-e-Akram hospital. They were transferred
to media in normal saline and frozen to –20°C.
DNA extraction
A hundred mg of each sample was added to 1mililiter
(mL) of lysis buffer (containing of 2 mg (mg)/mL, protein-
ase K) and the tube was placed in 56°C overnight. Then
DNA extraction was carried out according to Phenol-
Chloroform extraction method. It was kept in –20°C.
Primers design
Two20-baseprimers:upstreamprimer1520–1522nucleo-
tide position (n.p.):5'-3' AATACACCAACGCCTCCAAG
and downstream primer, 1935–1955 nucleotide position
(n.p.): 5'-3' ATCTCAAGCTAACAGCCAAAA) were
designed by primer 3 computer software. Analysis of pri-
mers by BLAST software showed that both primers had
100%homologywithHPgenomeandcould identifydiffer-
ent strains. These primers targeted CagA gene of HP (full
genome sequence NCBI: FJ42821501 associated number)
andamplifieda496-pbfragment.
In-house PCR optimization
PCR optimization was performed using various amounts of
magnesium chloride 2 (MgCl2), dNTPs, primers and differ-
ent annealing temperatures using several dilution of tem-
plate DNA. To amplify the fragments in each sample, 10 μl
(1 μg) extracted DNA was added to a reaction mixture con-
taining dNTPs, 200 μM; 10 pmol of each primer, MgCl2
1 μl; 50 mM and Taq DNA polymerase, 1U; (Ferments,
Lithuania) in a total reaction volume of 25 μl. The samples
were amplified for 40 cycles in an oil free automated ther-
mal, verity of ABI, USA consisting of first denaturation at
94°C for 5 min, followed by cycles of denaturation at 94°C
for 30 s, annealed at 50°C for 30 s and extension at 72°C
for 40 s, with a final incubation at 72°C for 5 min. The PCR
products were separated on 3 % agarose gel and stained
with 3 μg/ml ethidium bromide solution. The stained gel
was photo grated using gel documentation instrument with
a digital imaging camera system (UV tech, Germany).
Check list and analysis
To gather patients’ data, the drug history specially any
anti HP drugs, and the results of their own biopsies and
in-house PCR, were entered to a self-designed check list.
We used SPSS software version17 for analysis.
To describe the prevalence of different qualitative vari-
ables descriptive indexes were used. Also mean andstandard deviation (SD) were used to present quantitative
variables.
Results
Of 55 patients, 33 (60 %) were male. The mean age was
22 ± 10.57 years old with the range of 5 to 55 years of
age. None of the patients used any drugs during the last
month. None of them had any symptoms of GERD. Also
the patients didn’t undergo any upper gastroesophageal
tract manipulations, previously. Polyp was the most preva-
lent disorder among our patients (38.18 %). The preva-
lence of positive results among each group of patients is
shown in Table 1.
In-house PCR of HP DNA revealed positive results in
5 of 55 patients (9.09 %). Fifty five specimens included
21polyps (38.18 %), 14 nodules (25.45 %) and 20 cases of
papillomatosis (36.36 %). Of the specimens which were
positive for HP, 3 (60 %) were polyp, 1 (20 %) was nodule
and 1 (20 %) was papilloma.
Discussion
HP was identified as a risk factor for lots of malignan-
cies. About half of the persons around the world are
infected by HP [16,17].
If HP involves the parts surrounding the lower esopha-
geal sphincter, the probability of GERD increases. GERD
increases the risk of malignancies in upper parts of gas-
tro-esophageal tract. Of the organs located in the tract,
larynx is prone to laryngeal carcinoma [18,19]. Also HP
can be one of the risk factors of nasal polyp by causing
chronic inflammation [11,20-24].
Among the studies investigated the relationships be-
tween GERD and laryngeal injuries, Koufman showed
that 40–60 % of patients with voice disorders were pre-
sented by reflux symptoms [25]. Batch found the preva-
lence of 63 % of esophagitis in patients with laryngitis
[26]. Paterson detected GERD in 26 % of patients with
laryngeal disorders [27]. Because HP infection in stom-
ach and so its distribution to esophagus was prevalent
among the Iranian people [28], we didn’t investigate HP
in esophagus in our study. In addition, our patients
didn’t agree to undergo endoscopy. But HP infection was
not usual in larynx.
In 2004, Ahmet Kizilay, et al. refused the presence of
HP in their specimens from 69 cases with squamus cell
carcinoma (SCC) and 30 patients with non-neoplastic
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the same year, Nihat Akbayir, et al. didn’t find HP in the
specimens from patients with laryngeal SCC (50) by
means of histology [11].
Furthermore, the presence of HP in malignant laryn-
geal lesions (by using immunohistochemical methods
and light microscope) was compared with the presence
of HP in benign laryngeal lesions (by histopathology)
[11].
Prior to invasive methods, some investigators evaluated
the serologic changes in HP infected patients and the
prevalence of laryngeal cancer. Their results were in con-
flict. Some studies revealed significant differences between
the prevalence of HP in patients with laryngeal cancer and
the control group [29-31]. The results of the correlation
between HP existence and laryngeal tumors were different
[32]. In the other hand, some studies revealed that HP was
not detected in malignant laryngeal lesions by immunohis-
tochemical methods but there were some positive results
by histological evaluations. Also they did not find HP
tracks in specimens with benign laryngeal lesions in that
study. The authors supposed that spontaneous eradication
of HP in the malignant tissues which are surrounded by
atrophic areas is the reason of their findings but this theory
could not explain the absence of HP in non-atrophic tis-
sues [11]. Some articles revealed a high prevalence of HP
in patients with squamous cell carcinoma (SCC) of the lar-
ynx by serology [30,33,34].
According to our search, except a case report in
which the diagnosis of HP was confirmed by PCR in a
patient with laryngeal MALT lymphoma [15,35], there
was no specific method used for confirming HP in la-
ryngeal cancers without false positive result [36]. PCR
was used in a study in Turkey that studied 32 patients
with nasal polyps, 9 patients with SCC, 5 patients with
chronic inflammation, 8 cases with laryngeal nodules, 2
cases with laryngeal papillomatosis, 2 with laryngeal
polyps, one with laryngeal web, one with laryngeal dys-
plasia, and one with laryngeal hemangioma. By using
real-time PCR, they found HP DNA in 19 of 32 nasal
polyps, and in 17 of 29 laryngeal samples with other
disorders [15]. Also cag A of HP was found in 30 % of
tonsil and adenoid tissues by real-time PCR and in
24.6 % of the same tissues by in house PCR [24,37]
(Table 1).
By our investigation, according to the high specificity
and sensitivity of in-house PCR, we found HP in the
patients with benign laryngeal lesions including polyp,
nodule and papilloma.
Although the number of cases in this study was more
than other previous studies, most of our patients could
not be entered following the usage of anti HP drugs.
Most of our patients with papiloma used omeprazole
(as a self therapy) to relieve their upper gastrointestinalsymptoms. Thus we missed lots of our cases for this
study due to the high prevalence of anti HP drugs con-
sumers among our patients. We excluded patients with
GERD symptoms, but because of logical aspects, we
could not use 24-h PH monitoring or endoscopy to
confirm the diagnosis.
In our study the samples should be sent for pathology
and genetic studies. Some of the excised lesions were too
small to be divided to two parts and thus we could not
investigate HP genomes in some small species.
Conclusion
Although the number of our positive results was not a
lot, it was in contrast with previous studies which could
not find any HP tracks in benign laryngeal lesions by
other methods. More studies about the prevalence of HP
in benign laryngeal lesions improve judging about the
casualty of this infection in benign laryngeal lesions.
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